GIONCO DAVID (Chief Accounting Officer) received a stock award from STEMLINE THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 2/8/2019ACC: 0001104659-19-006896
Officer· Chief Accounting Officer
Since Feb 2019
+93.56K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
93.56K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
9.7%
12/21/2018
155.34K→170.34K
Common Stock
Direct
Shares
+69.55K
Price / share
—
Trade value
—
% of position
40.8%
2/6/2019
170.34K→239.90K
Common Stock
Direct
Shares
+9.01K
Price / share
—
Trade value
—
% of position
3.8%
2/6/2019
239.90K→248.90K
Total
Net shares
+93.56K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/21/2018 | A · Award | +15K | — | — | 9.7% | 155.34K | 170.34K |
| Common Stock Direct | 2/6/2019 | A · Award | +69.55K | — | — | 40.8% | 170.34K | 239.90K |
| Common Stock Direct | 2/6/2019 | A · Award | +9.01K | — | — | 3.8% | 239.90K | 248.90K |
| Total | +93.56K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported